Mitchell H. Gold
Independent DirectorDr. Mitchell H. Gold, also known as Mitch, M.D., serves as Venture Partner at Frazier Life Sciences Management, LP since January 09, 2025. He joined Frazier Life Sciences Management, LP on January 09, 2025. He is Independent Director of Attovia Therapeutics, Inc. from July 2024. He was Executive Chairman and Chief Executive Officer at Alpine Immune Sciences Inc. since January 2015 and June 2016 respectively. Dr. Gold served as the Executive Chairman, Chief Executive Officer and Assistant Secretary at Nivalis Therapeutics, Inc. since July 24, 2017. He was the Founder and Executive Chairman of Alpine Biosciences, Inc. Dr. Gold was the Founder and Managing Partner of Alpine BioVentures, GP, LLC. He served as the Chief Executive Officer and President of Dendreon Corp. from January 1, 2003 to February 1, 2012. He served as Vice President of Business Development at Dendreon from June 2001 to May 2002 and also served as its Chief Business Officer from May 2002 to December 2002. He served as an Executive Chairman of Dendreon Corp. from January 2012 to June 30, 2012 and served as its Executive Director from May 2002 to February 2013. From April 2000 to May 2001, he served as Vice President of Business Development and Vice President of Sales and Marketing for Data Critical Corporation. He was the Co-Founder of Elixis Corporation and also served as its Chief Executive Officer and President from 1995 to April 2000. Dr. Gold was a Resident Physician in the Department of Urology at the University of Washington. Dr. Gold serves as a Trustee of Cancer Research Institute, Inc. He has been a Director of SillaJen Biotherapeutics, Inc. since April 2012. Dr. Gold serves on the board of the University of Washington/Fred Hutchinson Cancer Research Center Prostate Cancer Institute. For his contributions to science and the treatment of cancer he was named a runner-up for Smartest CEO by Fortune Magazine and was honored with the 2011 Oliver R. Grace Award by the Cancer Research Institute. He was voted Entrepreneur of the Year in the Pacific Northwest in 2011 by Ernst and Young, as well as the top influencer in medicine in 2010 by Seattle Magazine. Dr. Gold was a Urology resident at the University of Washington. He has M.D. from Rush Medical College of Rush University Medical Center in 1993. Dr. Gold also earned a B.S. in Biology from the University of Wisconsin-Madison in 1989.
Positions
- Company NameAttovia Therapeutics, Inc.Stock CodeATTOPositionIndependent DirectorColleagues
- TFTao FuCEO, President & Director
- JNJames Newman TopperIndependent Chairman of the Board
- PVPetter VeibyChief Scientific Officer
- HCHubert C. ChenChief Medical Officer
- SCSteven ChanChief Financial Officer
- HZHangjun ZhanChief Technology Officer
- AJAngie J. YouIndependent Director
- JWJohn W. SmitherIndependent Director
